Tikun Olam, a medical cannabis provider in Israel known as T.O. Global LLC in North America, has partnered with CW Nevada LLC to bring its products into the state’s legal cannabis market. The announcement follows a successful pilot program in Delaware.
The products will be branded Tikun in the states and are expected to launch at CW Nevada dispensaries this month. Tikun will offer Avidekel, a high-CBD strain; Alaska, a high-THC sativa strain; Erez, Or, and Eran Almog, all high-THC indica strains; and Midnight, a one-to-one CBD-THC strain. The company’s products will be available in flower, cartridges, topicals, and edibles.
Bernard Sucher, CEO of T.O. Global, said the company sets “the gold standard for pharmaceutical grade medical cannabis production in both Israel and Canada.”
“The US cannabis market is becoming more sophisticated, looking beyond high-THC content to demand medically-proven, quality products for therapeutic cannabis use as part of a healthy lifestyle,” he said in a press release. “We are confident that entering the medical and adult-use U.S. market with a genuine approach to health and wellness, will position Tikun for a successful expansion where regulated markets exist.”
T.O. Global began its worldwide operations in 2015. In Israel, Tikun Olam has treated over 10,000 patients at its clinics.